Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Virobay
Virobay
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Virobay tees up a $50M IPO to get a trio of candidates into Phase II
Fierce Biotech
Virobay
IPOs
autoimmune disease
painkillers
Flag link:
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Virobay banks $8M to accelerate its treatments for pain, autoimmunity
Fierce Biotech
Virobay
autoimmune disease
neuropathic pain
VBY-036
VBY-376
Flag link:
Top 20 biotech licensing deals in H1 2012
Top 20 biotech licensing deals in H1 2012
Fierce Biotech
Xenon
Virobay
Tolero Pharmaceuticals
Threshold Pharmaceuticals
Novartis
Merck KGaA
Merck
MannKind
licensing
Janssen
Isis Pharmaceuticals
Ironwood
Inhibrx Thrombogenics
GSK
Genmab
Genentech
Galapagos
Forma Therapeutics
Endocyte
Endo
Enanta
Celgene
Bristol-Myers Squibb
Boehringer Ingelheim
Bionomics
Biogen Idec
BioDelivery Sciences
AstraZeneca
Angiochem
AC Immune
Abbott Laboratories
LEO Pharma
Flag link:
